Background Hypoxia preconditioning has been proven to be an effective method to enhance
the therapeutic action of mesenchymal stem cells (MSCs). However, the beneficial effects of …

BACKGROUND: It has been reported that ischemic postconditioning (IPO) or mesenchymal
stem cell (MSC) engraftment could protect organs from ischemia/reperfusion (I/R) injury. We …

Objectives: Bronchopulmonary dysplasia (BPD) is a significant global health problem and
currently lacks effective therapy. We established a neonatal rat model of BPD to investigate …

Abstract Background Mesenchymal stem cells (MSCs) have been reported to promote the
regeneration of injured tissue via their paracrine abilities, which are enhanced by hypoxic …

The secretome from hypoxia-preconditioned mesenchymal stem cells (MSCs) has been
shown to promote resolution of inflammation and alleviate acute lung injury (ALI) through its …

Hypoxia preconditioning has been confirmed as an effective strategy to enhance the
therapeutic potentials of mesenchymal stem cells (MSCs), such as for myocardial ischemia …

Hemorrhagic shock (HS) and trauma is currently the leading cause of death in young adults
worldwide. Morbidity and mortality after HS and trauma is often the result of multi-organ …

Lung transplantation is a lifesaving therapy for people living with severe, life‐threatening
lung disease. The high mortality rate among patients awaiting transplantation is mainly due …

Alveolar epithelial dysfunction induced by hypoxic stress plays a significant role in the
pathological process of lung ischemia-reperfusion injury (IRI). Mesenchymal stem cell …

Abstract Background Mesenchymal stem cells (MSCs) derived from bone marrow have
potent stabilizing effects for the treatment of acute respiratory distress syndrome (ARDS) …